Abstract
Ocular neovascularisation (ONV) is a pathological feature of many human blinding diseases. Here, we review current pharmacological therapies for these disorders and highlight emerging therapies in clinical trial for ONV. Finally, we discuss desirable characteristics of future ONV therapies, including innovative strategies for novel delivery to the back of the eye.
Author supplied keywords
Cite
CITATION STYLE
APA
Reynolds, A. L., Kent, D., & Kennedy, B. N. (2014). Current and emerging therapies for ocular neovascularisation. Advances in Experimental Medicine and Biology, 801, 797–804. https://doi.org/10.1007/978-1-4614-3209-8_100
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free